1.0STAThttps://www.statnews.comMeghana Keshavanhttps://www.statnews.com/staff/meghana-keshavan/rich600338<blockquote class="wp-embedded-content" data-secret="QfjTvx3Y9S"><a href="https://www.statnews.com/2024/05/06/biotech-news-merck-juul-pfizer-eyepoint-nasa-spark/">Merck may have a competition for ever-scarce BCG</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.statnews.com/2024/05/06/biotech-news-merck-juul-pfizer-eyepoint-nasa-spark/embed/#?secret=QfjTvx3Y9S" width="600" height="338" title="“Merck may have a competition for ever-scarce BCG” — STAT" data-secret="QfjTvx3Y9S" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); </script> https://www.statnews.com/wp-content/uploads/2017/11/GettyImages-182931587-1024x576.jpg1024576There’s long been a global shortage of the BCG vaccine for bladder cancer. But since ImmunityBio won FDA approval for Anktiva, an immunotherapy meant to be used along with the BCG vaccine, production for treatment is being kicked off on a global scale: